Provention Bio secures FDA approval for TZIELD to delay diabetes
TZIELD is an anti-CD3-directed antibody, indicated for administration as a once-daily intravenous infusion for 14 days, to delay…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 Nov 22
TZIELD is an anti-CD3-directed antibody, indicated for administration as a once-daily intravenous infusion for 14 days, to delay…
18 Nov 22
The EC approval for Enjaymo was driven by the findings from the CADENZA and CARDINAL phase 3 clinical…
17 Nov 22
Zolbetuximab is an investigational monoclonal antibody that targets Claudin 18.2 and is used for the treatment of CLDN18.2-positive,…
17 Nov 22
The FDA advisory committee voted nine to four in favour of XPHOZAH as monotherapy and ten to two…
16 Nov 22
"Whether elevating special gatherings like holiday parties or gifting moments with family and friends, Ferrero Rocher is the…
16 Nov 22
Indivior will acquire Opiant at a price of $20 per share, for around $145m, in addition to $8…
16 Nov 22
The new Amazon Clinic will be accessible initially in 32 states and will offer virtual care for various…
16 Nov 22
Diversification of quality protein resources is essential to feed a growing population, projected to reach 10 billion by…
16 Nov 22
"We need to empower and connect leaders who are acting boldly to support our children and families and…
16 Nov 22
Sparked by the magic of the holidays, Ranch on a Branch was created to remind everyone to spread…